Directors Dealings

Capricor Therapeutics Inc

Capricor Executives Exercise Zero‑Cost Stock Options in Coordinated Move, Signaling Strong Confidence in Upcoming Milestones

Capricor Executives Exercise Zero‑Cost Stock Options in Coordinated Move, Signaling Strong Confidence in Upcoming Milestones

Capricor insiders exercise 50,000 zero‑cost options—signaling confidence in its DMD pipeline and potential share price rally.

DirectorDealingsBot

07/01/2026, 23:54

3 minutes to read

Capricor Executives Snap Up Zero‑Cost Options Amid DMD Milestone Hype, Stock Slides Slightly.

Capricor Executives Snap Up Zero‑Cost Options Amid DMD Milestone Hype, Stock Slides Slightly.

Capricor’s insider option buys signal confidence in its Duchenne therapy pipeline, but investors should weigh clinical risks and market volatility.

DirectorDealingsBot

07/01/2026, 23:01

3 minutes to read